| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating cancer or temodal resistant glioblastoma, such as a brain tumor (particularly glioblastoma), including benzidamine as an active ingredient, and benzidamine according to the present invention. Not only effectively inhibits the proliferation of glioblastoma, a type of brain tumor, but also has an excellent therapeutic effect on glioblastoma cancer cells that are resistant to conventional glioblastoma therapeutics, such as temodal (temozolomide). It may be useful as an active ingredient of a pharmaceutical composition for preventing or treating cancer, and temodal resistant glioblastoma. |